Free Trial

Futura Medical (FUM) Competitors

Futura Medical logo
GBX 9.60 +1.60 (+20.00%)
As of 11:47 AM Eastern

FUM vs. SCLP, MPH, ORPH, OBI, REDX, ETX, SBTX, COS, C4XD, and DDDD

Should you be buying Futura Medical stock or one of its competitors? The main competitors of Futura Medical include Scancell (SCLP), Mereo BioPharma Group plc (MPH.L) (MPH), Open Orphan (ORPH), Ondine Biomedical (OBI), Redx Pharma (REDX), e-therapeutics (ETX), SkinBioTherapeutics (SBTX), Collagen Solutions plc (COS.L) (COS), C4X Discovery (C4XD), and 4D pharma (DDDD). These companies are all part of the "biotechnology" industry.

Futura Medical vs.

Scancell (LON:SCLP) and Futura Medical (LON:FUM) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, community ranking, valuation, institutional ownership, dividends, media sentiment, profitability, earnings and risk.

Scancell has a net margin of 0.00% compared to Futura Medical's net margin of -44.64%. Scancell's return on equity of 98.74% beat Futura Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
ScancellN/A 98.74% -45.28%
Futura Medical -44.64%-56.44%-26.59%

46.5% of Scancell shares are held by institutional investors. Comparatively, 35.7% of Futura Medical shares are held by institutional investors. 5.0% of Scancell shares are held by insiders. Comparatively, 32.1% of Futura Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Scancell has a beta of 0.35, meaning that its stock price is 65% less volatile than the S&P 500. Comparatively, Futura Medical has a beta of 1.25, meaning that its stock price is 25% more volatile than the S&P 500.

Scancell received 1 more outperform votes than Futura Medical when rated by MarketBeat users. Likewise, 74.50% of users gave Scancell an outperform vote while only 64.36% of users gave Futura Medical an outperform vote.

CompanyUnderperformOutperform
ScancellOutperform Votes
187
74.50%
Underperform Votes
64
25.50%
Futura MedicalOutperform Votes
186
64.36%
Underperform Votes
103
35.64%

Futura Medical has higher revenue and earnings than Scancell. Scancell is trading at a lower price-to-earnings ratio than Futura Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ScancellN/AN/A-£6.75M-£0.65-15.18
Futura Medical£8.68M3.45-£3.88M-£1.21-7.92

In the previous week, Scancell had 4 more articles in the media than Futura Medical. MarketBeat recorded 4 mentions for Scancell and 0 mentions for Futura Medical. Scancell's average media sentiment score of 0.90 beat Futura Medical's score of 0.00 indicating that Scancell is being referred to more favorably in the media.

Company Overall Sentiment
Scancell Positive
Futura Medical Neutral

Summary

Scancell beats Futura Medical on 8 of the 14 factors compared between the two stocks.

Get Futura Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for FUM and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FUM vs. The Competition

MetricFutura MedicalBiotechnology IndustryMedical SectorLON Exchange
Market Cap£29.92M£128.48M£5.33B£2.62B
Dividend Yield4.55%3.74%5.21%5.05%
P/E Ratio-7.923.4026.71129.34
Price / Sales3.454,120.92386.13221,585.85
Price / Cash20.4313.1938.2528.03
Price / Book3.7133.136.773.79
Net Income-£3.88M-£91.56M£3.23B£5.88B
7 Day Performance10.34%2.88%1.80%0.62%
1 Month Performance3.23%7.98%11.10%22.12%
1 Year Performance-75.54%99.22%17.11%120.95%

Futura Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FUM
Futura Medical
N/AGBX 9.60
+20.0%
N/A-79.2%£29.92M£8.68M-7.9212Gap Up
SCLP
Scancell
N/AGBX 9.47
+2.3%
N/A-2.0%£98.03MN/A-14.5151News Coverage
Insider Trade
MPH
Mereo BioPharma Group plc (MPH.L)
N/AN/AN/AN/A£89.76MN/A-0.2150Gap Down
ORPH
Open Orphan
N/AN/AN/AN/A£67.09M£34.71M-25.30179
OBI
Ondine Biomedical
N/AC$8.50
flat
N/A+25.9%C$61.12MC$48,596.29-2.56N/A
REDX
Redx Pharma
N/AN/AN/AN/A£58.35M£4.20M-150.00101Gap Up
High Trading Volume
ETX
e-therapeutics
N/AN/AN/AN/A£52.59M£295,000.00-450.0035High Trading Volume
SBTX
SkinBioTherapeutics
N/AGBX 18.73
-0.1%
N/A+85.0%£42.78M£1.56M-11.5211News Coverage
COS
Collagen Solutions plc (COS.L)
N/AN/AN/AN/A£30.99M£4.01M-8.283,350
C4XD
C4X Discovery
N/AN/AN/AN/A£30.27M£24.68M300.0049High Trading Volume
DDDD
4D pharma
N/AN/AN/AN/A£30.05M£718,000.00-1.08106

Related Companies and Tools


This page (LON:FUM) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners